Navigation Links
Specialized Adult Stem Cells Re-Grow Fingertips
Date:8/24/2011

WEDNESDAY, Aug. 24 (HealthDay News) -- Specialized adult stem cells are make it possible for mammals to re-grow the tips of injured fingers or toes, rather than a "jack of all trades" cell type formed in response to serious injury, a new study shows.

Researchers from Stanford University found the regenerating stem cells are tissue-specific, meaning each has a particular job regenerating bone, skin, tendon, vessels or nerves.

The findings call into question a popular theory that damaged extremities are regenerated by a bump of cells considered "pluripotent," meaning that they are able to grow into a variety of cell types. This versatile bump of repair cells is called a blastema, but it appears to have nothing to do with fingertip regeneration.

"We've shown conclusively that what was thought to be a blastema is instead simply resident stem cells that are already committed to become specific tissue types," said Dr. Irving Weissman, director of Stanford's Institute for Stem Cell Biology and Regenerative Medicine in a news release. "The controversy about limb regeneration in mammals should be over."

Mice and some humans have the ability to re-grow the tips of injured fingers or toes. To better understand how they do this, Stanford researchers labeled specific tissue types of mice with fluorescent colors before cutting off a small part of the mice's toes. Over the course of three months, they examined the regenerated tissue.

The researchers found that each tissue type -- such as that found in nail, bone, tendon or blood vessels -- could only give rise to that type of tissue, Weissman said. "There was no cross-contribution between tissue types or germ layers," he said.

"I was extremely surprised," confessed first author Yuval Rinkevich. "I began the experiment very eager to find something like...one tissue type becoming another. But this is clearly not the case."

He and the other researchers noted, however, the findings could help develop ways to enhance regeneration in humans.

"Here we are characterizing and learning about a naturally occurring regeneration phenomenon without adding other genes," said Rinkevich. "We want to first understand how normal tissue regeneration works. Then we can try to exploit that knowledge to perhaps enhance the growth of digits or limbs in humans."

The researchers pointed out they also dismissed the alternate theory that stem cells circulating in the blood could play a role in this type of regeneration.

The study, published in the Aug. 24 issue of Nature, did not discredit previous studies showing that it is possible to persuade specialized adult cells to turn into cells very similar to embryonic skin cells.

More information

The National Institutes of Health provides more information on stem cell research.

-- Mary Elizabeth Dallas

SOURCE: Stanford University School of Medicine, news release, Aug. 24, 2011.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Specialized regulatory T cell stifles antibody production centers
2. Specialized blood plasma treatment does not improve rotator cuff healing, study finds
3. Clinical waste management needs specialized regulation
4. The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services
5. Serving the World With Specialized Insurance for Missionaries
6. Racial disparities diminish in specialized cancer centers
7. Chateau Amber Retreat Provides Specialized Post-Cosmetic Surgery Care in Palm Springs Luxury
8. CareTech Solutions Presents Specialized Healthcare Call Center at HIMSS10
9. Short on specialized intensive care physicians, team-based approach improves ICU outcomes
10. Kellogg researcher helping eye care providers better assess driving in older adults
11. Study Shows Key Ways Young Adults Can Find, Keep a Job
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Specialized Adult Stem Cells Re-Grow Fingertips
(Date:6/28/2017)... Clara, CA (PRWEB) , ... June 28, 2017 , ... ... hosting a free AFM Luncheon for all SEMICONWest attendees and Park customers ... luncheon will feature talks from Dr. Sang-il Park, Chairman & CEO of Park Systems, ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... County and the surrounding regions access to insurance assistance and financial planning services, ... 25: Ministries to assist families in the region facing financial crisis. , Matthew ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel ... Mike Finnegan to the position of Executive Vice President, Sales and Marketing. Finnegan ... technology, telehealth and medical device sales leadership. He has received industry recognition for ...
(Date:6/27/2017)... ... 27, 2017 , ... Harbour , a DAO (decentralized autonomous organization) that ... has released their technical specifications . , 2017 has seen an explosion of ... for determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... SUNucate efforts, Louisiana became the sixth state to pass legislation which ensures ... John Bel Edwards’ signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)...  Leaf Healthcare, recognized for developing one of ... ulcer prevention, will unveil its comprehensive mobility monitoring ... Nurses, National Teaching Institute and Critical Care Exposition ... Patient Monitoring System is the first mobility monitoring ... system seamlessly tracks patient movement throughout the mobility ...
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
Breaking Medicine Technology: